Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early
Margolis, H.S.; Presson, A.C.
JAMA 270(24): 2971-2972
1993
ISSN/ISBN: 0098-7484 PMID: 8254860 Document Number: 413761
Document emailed within 1 workday
Related Documents
Lee, C.Y.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Dumas, R.; Milcamps, B.; Lin, W. 2000: Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 29-36Shi, J.; Li, Z.; Zheng, L. 2001: Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine (YDV) on adults Zhonghua Liu Xing Bing Xue Za Zhi 22(2): 105-107
Bulkow, L.R.; McMahon, B.J.; Wainwright, R.B.; Parkinson, A.J.; Wainwright, K.Y.; House, J. 1993: Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults Arctic Medical Research 52(3): 118-126
Mbunda, T; Bakari, M; Tarimo, E; Sandstrom, E; Kulane, A 2014: Factors that Influence the Willingness of Young Adults to Participate in Early Vaccine Trials and Contraceptive Practices in Dar es Salaam, Tanzania Aids Research and Human Retroviruses 30(S1): A247-A247
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692
Gil, A.; Dal-Ré, R.; González, A.; Lasheras, L.; Aguilar, L.; del Rey, J. 1995: Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults Medicina Clinica 104(4): 126-129
Nitayaphan, S.; Pitisuttithum, P.; Karnasuta, C.; Eamsila, C.; de Souza, M.; Morgan, P.; Polonis, V.; Benenson, M.; VanCott, T.; Ratto-Kim, S.; Kim, J.; Thapinta, D.; Garner, R.; Bussaratid, V.; Singharaj, P.; el-Habib, R.; Gurunathan, S.; Heyward, W.; Birx, D.; McNeil, J.; Brown, A.E. 2004: Safety and immunogenicity of an HIV subtype B and e prime-boost vaccine combination in HIV-negative Thai adults Journal of Infectious Diseases 190(4): 702-706
Moyes, C.; Milne, A. 1988: Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children New Zealand Medical Journal 101(843): 162-164
Aspinall, S.; Kocks, D.J. 1998: Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation South African Medical Journal 88(1): 36-39
Stoute, Jé.A.; Heppner, D.Gray.; Mason, C.J.; Siangla, J.; Opollo, M.O.; Kester, K.E.; Vigneron, L.; Voss, G.; Walter, M.J.; Tornieporth, N.; Cohen, J.D.; Ballou, W.Ripley. 2006: Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya American Journal of Tropical Medicine and Hygiene 75(1): 166-170
Fu, Q.-p.; He, H.; Li, L.; Chen, H.-p.; Zeng, Y.-x.; Liu, Q.-l.; Fang, G.; Dong, C.-m.; Guo, S.-h.; Li, H.-g.; Wang, H.-y.; He, C.-s.; Zhou, S.-z.; Li, L.; Gu, S.-n.; Zhang, Z.-f.; Dai, M. 2009: The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population Zhonghua Yu Fang Yi Xue Za Zhi 43(10): 903-906
Shah, R.; Raghu, M.B.; Shivananda, A.; Mangayarkarasi, S.; Rao, I.; Rao, R.; Bhusari, P.; Joseph, C.A.; Reddy, R. 2008: Immunogenicity and safety of an indigenously developed DTPw hepatitis B combination vaccine in Indian infants Indian Pediatrics 45(10): 819-823
Schiff, G.M.; Sherwood, J.R.; Zeldis, J.B.; Krause, D.S. 1995: Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 16(1): 12-17
Petersen, K.; Bulkow, L.; McMahon, B.; Wainwright, R.; Peters, H. 1998: Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants International Journal of Circumpolar Health 57(Suppl 1): 285-292
Abarca, K.; Valdivieso, F.; Potin, M.; Ibáñez, I.; Vial, P. 2002: Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults Revista Medica de Chile 130(5): 502-510
Joshi, N.; Kumar, A.; Raghu, M.B.; Bhave, S.; Arulprakash, R.; Bhusari, P.; Rao, R. 2004: Immunogenicity and safety of hepatitis B vaccine (Shanvac-B) using a novel pre-filled single use injection device Uniject in Indian subjects Indian Journal of Medical Sciences 58(11): 472-477
Chan, S.H.; Tan, P.T.N.; Han, H.H.; Bock, H.L. 2006: Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults Singapore Medical Journal 47(4): 286-290
Ricciardi, G.; Graziano, G. 1990: Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel Bollettino dell'Istituto Sieroterapico Milanese 69(2): 385-390
Corbella, E.; Garghetti, L.; Poloniato, A.; Zambelloni, C.; Consonni, A. 1987: Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses Minerva Pediatrica 39(20): 821-826
Huu, T.Ngoc.; Phuong, N.Thi.Minh.; Toan, N.Trong.; Thang, H.Vinh. 2015: Immunogenicity and Safety of Quinvaxem® (Diphtheria, Tetanus, Whole-Cell Pertussis, Hepatitis B and Haemophilus Influenzae Type B Vaccine) Given to Vietnamese Infants at 2 to 4 Months of Age Southeast Asian Journal of Tropical Medicine and Public Health 46(4): 753-763